Previous 10 | Next 10 |
Rexahn Pharmaceuticals (NASDAQ: REXN ) has agreed to merge with privately held Ocuphire Pharma, a developer therapies for eye disorders, in an all-stock deal. More news on: Rexahn Pharmaceuticals, Inc., Healthcare stocks news, Merger & acquisition news, Stocks on the move, Read m...
Transaction to Create a Nasdaq-listed Biopharmaceutical Company Focused on Advancing Ocuphire’s Late-Stage Clinical Pipeline of Ophthalmic Drug Candidates $21.15 Million Investment Committed by Institutional Healthcare and Accredited Investors ROCKVILLE, Md. and FARMINGTON H...
Zosano Pharma (NASDAQ: ZSAN ) -47% after pricing stock offering. More news on: Zosano Pharma Corporation, PolarityTE, Inc., PDS Biotechnology Corporation, Stocks on the move, , Read more ...
These Penny Stocks Are Hot Right Now; Will It Last? If you’re interested in making money with penny stocks , you’ll need to have a handle on risk. I think that’s safe to say for any type of investment. But for these cheap stocks, that risk is high but the rewards could be...
Gainers : Rexahn Pharmaceuticals (NASDAQ: REXN ) +85% . More news on: Rexahn Pharmaceuticals, Inc., Sprint Corporation, Genprex, Inc., Stocks on the move, , Read more ...
Thinly traded nano cap Rexahn Pharmaceuticals ( REXN +76.1% ) is up on a whopping 130x surge in volume in reaction to its out-license agreement with Zhejiang HaiChang Biotechnology Co., Ltd., for candidate RX-0201 and nano-liposomal formulations of RX-0201 named RX-0301 and RX-0047. Mo...
Sprint (NYSE: S ) +74% after judge approves T-Mobile merger . More news on: Sprint Corporation, Rexahn Pharmaceuticals, Inc., ZK International Group Co., Ltd., Stocks on the move, Read more ...
Thinly traded nano cap Rexahn Pharmaceuticals ( REXN +52.4% ) is up on an 24x surge in volume, albeit on turnover of only 899K shares, in apparent response to encouraging preclinical data on pipeline candidate RX-5902. The results were just published in the journal Molecular Cancer Ther...
Gainers: Rexahn Pharmaceuticals (NASDAQ: REXN ) +45% . California Resources Corporation (NYSE: CRC ) +40% . BeiGene (NASDAQ: BGNE ) +34% . El Pollo Loco Holdings (NASDAQ: LOCO ) +28% . Acorda Therapeutics (NASDAQ: ACOR ) +26% . American Axle & Manufacturing Holdings (NYSE: A...
ROCKVILLE, Md., Sept. 24, 2019 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NasdaqCM: REXN) today announced that it has commenced a process to explore and evaluate strategic alternatives to enhance shareholder value. Rexahn has engaged Oppenheimer & Co., Inc. as its financial advis...
News, Short Squeeze, Breakout and More Instantly...
Rexahn Pharmaceuticals Company Name:
REXN Stock Symbol:
NYSE Market:
FARMINGTON HILLS, Mich., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of several eye disorders, today announced that will participate in the H.C. Wainwrigh...
Merger completed with Rexahn Pharmace u ticals c reat ing a Nasdaq-listed Biopharmaceutical Company Focused on Advancing Ocuphire’s Late-Stage Clinical Pipeline of Ophthalmic Drug Candidates Trading under "OCUP" on the Nasdaq Capital Market to begin No...
ROCKVILLE, Md., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NASDAQ:REXN) (“Rexahn”) announced today that the merger transaction between Rexahn and Ocuphire Pharma, Inc. is expected to be effective shortly after 4:00 pm (EST) today, Thursday, November 5, 202...